Molecular Mechanisms of Sod1 Maturation Processes
Copper ions are tightly regulated by aerobic organisms to the extent that labile copper is virtually undetectable.
Although elevated levels are toxic, the capacity to interconvert between oxidation states (e.g. Cu(I) and Cu(II))
makes copper ions useful for a wide variety of cellular processes. Copper (and other redox-active metal ions)
is constantly guarded from promiscuous reactions in the cytosol by a diverse group of sequestering agents that
include trafficking proteins and molecular scavengers. Metallo-chaperones are a diverse family of trafficking
molecules that provide metal ions to protein targets for use as cofactors. One such target is the ubiquitous
antioxidant enzyme copper-zinc superoxide dismutase (Sod1). The copper chaperone for Sod1 (Ccs1)
delivers a single copper ion to the active-site and catalyzes oxidation of the disulfide bond within Sod1 through
a mechanistically ambiguous process. These Ccs1-mediated posttranslational modifications transform
immature Sod1 from a collection of marginally stable, inactive monomers into a remarkably stable, active
homodimer. Mutations in the gene that code for Sod1 have been implicated in the fatal neurodegenerative
disorder amyotrophic lateral sclerosis (ALS). Interestingly, it is the immature forms of these pathogenic Sod1
variants that make up the disease related aggregates found in susceptible cells. We have determined the
structure of full-length Ccs1 bound to an immature form of Sod1 at 2.35 Å. The structure of the heterocomplex
reveals a previously unobserved β-hairpin conformation of the Ccs1 C-terminal domain (D3) suggestive of a
“pivot and release” mechanism for Ccs1 action. We suggest that Ccs1 binding to an immature form of Sod1
induces movement of a conserved loop element in Sod1 that exposes an electropositive hole and proposed
“entry site” for copper ion delivery to Sod1. We have since our current Sod1•Ccs1 heterocomplex structure for
a structure-based approach to investigate Ccs1 action using the following methods (I) a fluorescence based
system designed to delineate the thermodynamics guiding Ccs1-mediated maturation of wild-type and mutant
forms of Sod1, (II) structural characterization of additional Sod1•Ccs1 heterocomplexes at progressive steps in
the maturation process, (III) X-ray absorption spectroscopy and related techniques to probe copper ion
coordination at the Sod1 “entry site” and (IV) cell-based biochemical analysis focusing on connecting catalytic
turnover at the Sod1 “entry site” and a sulfenic acid intermediate to disulfide bond formation and release of the
copper ion to the Sod1 active site. The aims presented here are designed to end the ongoing debate
regarding a universal mechanism for Sod1 maturation via Ccs1 and may help to illustrate the initial stages of
the Sod1-linked neurodegenerative disorder ALS.
Public Health Relevance Statement
Project Narrative
Metallochaperones exist as part of a multi-pronged defense force used by aerobic organisms to guard against
toxic levels of oxidative stress. We use a structure-guided approach to develop a complete molecular
mechanism for the action of one of these molecules, the copper chaperone for superoxide dismutase 1 (Ccs1).
The central aim is to delineate the processes of copper ion delivery and disulfide bond formation in the
important antioxidant enzyme copper-zinc superoxide dismutase (Sod1) catalyzed by Ccs1.
No Sub Projects information available for 5R01GM120252-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01GM120252-05
Patents
No Patents information available for 5R01GM120252-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01GM120252-05
Clinical Studies
No Clinical Studies information available for 5R01GM120252-05
News and More
Related News Releases
No news release information available for 5R01GM120252-05
History
No Historical information available for 5R01GM120252-05
Similar Projects
No Similar Projects information available for 5R01GM120252-05